// App-Quantinova.ai

1385 : In vitro evaluation of platinum chemotherapy combinations with the ATR inhibitor, ceralasertib (AZD6738)

Researchers

Presenter

  • Sally E. Hall

Principal Investigators

  • Alan Lau

  • Emma Dean

  • Elizabeth Martin

  • Christopher Ottley

  • Yvette Drew

  • Gareth Veal

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Durham University, Durham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Ataxia Telangiectasia And Rad3-Related Protein

Drug/Treatment

  • Cisplatin

  • AZD6738

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02264678

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved